Zodryl Dec 25
Product Images NDC 43378-120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zodryl Dec 25 (NDC 43378-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Codadose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fa37ced4-figure-01 (Fa37ced4 Figure 01)

The packaging label for Zodryl DEC 25 liquid decongestant/expectorant/cough suppressant by CodaDose, Inc. The front panel displays the proprietary name Zodryl DEC 25, active ingredients Pseudoephedrine HCl, Guaifenesin, and Codeine phosphate, and grape flavor. The label includes dosage form as a 4 fl oz (118 mL) bottle, a barcode, and a note to use with the enclosed CodaDose oral dispenser. The label also features color-coded drug action categories and patient instruction reminders.*

FDA Label Image

Fa37ced4-figure-02 (Fa37ced4 Figure 02)

Drug Facts panel of Zodryl DEC 25 by CodaDose, Inc. The active ingredients listed per mL are codeine phosphate 1 mg (cough suppressant), guaifenesin 20 mg (expectorant), and pseudoephedrine HCl 5 mg (decongestant). The uses describe relief of cough due to minor throat and bronchial irritation linked to common cold or inhaled irritants, with effects on cough intensity, nasal congestion, and mucus passage. The continued section lists inactive ingredients and contact information for questions.*

FDA Label Image

Fa37ced4-figure-03 (Fa37ced4 Figure 03)

Drug Facts panel continuation for Zodryl DEC 25 including warnings such as not to use in children with chronic pulmonary disease or taking certain drugs, instructions to ask a doctor before use if the child has certain conditions, directions for use every 4-6 hours with an enclosed calibrated oral dispenser, and other information about storage temperature. It also advises to stop use and seek a doctor if cough persists more than one week with additional symptoms, and to keep the product out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.